NCT03939117

Brief Summary

The aim of this study is to evaluate if an intraoperative protocol for Ultrasound scan (USS) is feasible and safe in patients undergoing elective surgery for ileocolic CD. The results of this study could guide the development of a larger randomised trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 19, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 26, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 6, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2020

Completed
Last Updated

June 22, 2020

Status Verified

June 1, 2020

Enrollment Period

1.1 years

First QC Date

March 26, 2019

Last Update Submit

June 19, 2020

Conditions

Outcome Measures

Primary Outcomes (9)

  • Number of intraoperative USS assessments completed.

    Recording the number of intraoperative surgery completed

    Day of surgery

  • Number of adverse events reported during surgery.

    Recording the number of adverse events reported during the surgey

    Day of surgery

  • To record the incidence of crohn's disease identified at macroscopic intraoperative assessment of the small bowel by the surgeon, and the intraoperative USS assessment of the small bowel.

    recording the incidence of crohn's disease identified following assessment of the small bowel by the surgeon macroscopcially

    Day of surgery

  • To record the length of areas affected by crohn's disease identified at macroscopic intraoperative assessment of the small bowel by the surgeon

    Measurement in centimeters of the length of bowel affected by crohn's disease as identified by the surgeon macroscopically

    Day of surgery

  • To compare the incidence of crohn's disease indentified macroscopically by the surgeon with the intraoperative ultrasound assessment

    compare the incidence of crohn's disease identified by the surgeon with the incidence of crohn's disease identified by the intraoperative ultrasound assessment

    Day of surgery

  • To compare the length of crohn's disease identified marcoscopically by the surgeon with the intraoperative ultrasound assessment

    compare the length of crohn's disease in centimetres identified by the surgeon with the incidence of crohn's disease identified by the intraoperative ultrasound assessment

    Day of surgery

  • To evaluate the feasibility of study delivery, i.e. recruitment of study participants and retention at follow-up visits.

    Feasibility of data collection required for a future trial measured by number of eligible participants, the proportion of patients consenting for the study, the proportion of recruited participants with all the required baseline and follow-up assessments completed, proportion of withdrawals from follow-up data collection, reasons for withdrawal and number of losses to follow-up.

    6 week follow up

  • To record surgical and patient outcomes up to 6 weeks

    Operating time (Kaplan-Meier analysis), intra- and post-operative complication rates, 30 day morbidity and mortality rate

    30 day morbidity

  • To evaluate the direct and indirect costs of a standardised intraoperative USS protocol.

    Annotation of key steps for performance of small bowel intraoperative USS in patients with CD.

    1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The target population is adults (18+ years) undergoing elective surgery (i.e. planned operation) for CD affecting the small bowel.

You may qualify if:

  • Aged 18 years or over
  • American society of Anaesthesiologists (ASA) grade I, II or III
  • Undergoing elective surgery to remove part of the terminal ileum which is affected by CD.
  • Indication for surgery agreed at IBD MDT meeting
  • Able to give written informed consent

You may not qualify if:

  • Undergoing emergency surgery
  • Previous abdominal surgery for CD
  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Portsmouth Hospitals NHS Trust

Portsmouth, Hampshire, PO6 3LY, United Kingdom

Location

MeSH Terms

Conditions

Crohn DiseaseInflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Officials

  • Valerio Celentano

    Portsmouth Hospitals NHS Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2019

First Posted

May 6, 2019

Study Start

January 19, 2019

Primary Completion

March 9, 2020

Study Completion

March 9, 2020

Last Updated

June 22, 2020

Record last verified: 2020-06

Locations